IP Library Granted Patent US 7,659,072
Granted Patent B2
US 7,659,072 · App. 12/186,127 · Granted Feb 9, 2010

Methods for using riboprimers for strand displacement replication of target sequences

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,659,072
App. No.
12/186,127
Granted
Feb 9, 2010
Kind
B2
Abstract

Methods, compositions and kits for amplifying a target sequence by strand displacement replication using strand-displacing primers. The method uses primers that have only ribonucleotides or purine ribonucleotides and at least one 2′-substituted pyrimidine-2′-deoxyribonucleotide.

Claims (21)

1. A method for amplifying a target nucleic acid sequence comprising a target nucleic acid:

a) hybridizing a Riboprimer to a single stranded DNA template comprising the target nucleic acid sequence, wherein said Riboprimer comprises: i) only ribonucleotides, or ii) only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′-position of the deoxyribose sugar moiety;

b) extending the Riboprimer with a DNA polymerase having strand displacement activity;

c) cleaving the annealed Riboprimer with an RNase H enzyme such that another Riboprimer hybridizes to the template and repeats primer extension by strand displacement, whereby multiple copies of the complementary sequence of the target sequence are produced; and

d) attaching the multiple copies of the complementary sequence of the target sequence onto a solid substrate to make a microarray of the amplified products.

2. The method of claim 1 , wherein a plurality of Riboprimers is used.

3. The method of claim 1 wherein the Riboprimer comprises only ribonucleotides.

4. The method of claim 1 wherein the Riboprimer comprises at least one pyrimidine 2′-deoxyribonucleotide having a 2′-substituent on the sugar moiety.

5. The method of claim 1 wherein the Riboprimer comprises at least one pyrimidine 2′-fluoro-2′-deoxyribonucleotide.

6. The method of claim 1 wherein the Riboprimer comprises purine ribonucleotides and pyrimidine 2′-fluoro-2′-deoxyribonucleotides.

7. The method of claim 1 wherein the Riboprimer comprises AMP, GMP, 2′-F-dUMP and 2′-F-dCMP.

8. A method for amplifying a target nucleic acid sequence comprising a target nucleic acid:

a) hybridizing a Riboprimer to a single stranded DNA template comprising the target nucleic acid sequence, wherein said Riboprimer comprises: i) only ribonucleotides, or ii) only purine ribonucleotides and only pyrimidine nucleotides, wherein at least one of the pyrimidine nucleotides is a pyrimidine 2′-deoxyribonucleotide having a non-canonical substituent, which substituent is neither an H nor an OH, on the 2′-position of the deoxyribose sugar moiety;

b) extending the Riboprimer with a DNA polymerase having strand displacement activity;

c) cleaving the annealed Riboprimer with an RNase H enzyme such that another Riboprimer hybridizes to the template and repeats primer extension by strand displacement, whereby multiple copies of the complementary sequence of the target sequence are produced; and

d) hybridizing the multiple copies of the complementary sequence of the target sequence to a microarray of nucleic acid molecules immobilized on a surface of a solid phase.

9. The method of claim 8 , wherein a plurality of Riboprimers is used.

10. The method of claim 8 wherein the Riboprimer comprises only ribonucleotides.

11. The method of claim 1 wherein the Riboprimer comprises at least one pyrimidine 2′-deoxyribonucleotide having a 2′-substituent on the sugar moiety.

12. The method of claim 1 wherein the Riboprimer comprises at least one pyrimidine 2′-fluoro-2′-deoxyribonucleotide.

13. The method of claim 1 wherein the Riboprimer comprises purine ribonucleotides and pyrimidine 2′-fluoro-2′-deoxyribonucleotides.

Assignments (4)
MERGER Recorded Dec 3, 2020
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ILLUMINA, INC.
Reel/Frame 054585/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2017
From: CELLSCRIPT, INC.
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 041947/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2011
From: EPICENTRE TECHNOLOGIES CORPORATION
To: CELLSCRIPT, INC.
Reel/Frame 027242/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2008
From: DAHL, GARY A; JENDRISAK, JEROME J; RADEK, AGNES J
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 021666/0573 →